SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-010889
Filing Date
2020-06-09
Accepted
2020-06-09 21:33:56
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4322
  Complete submission text file 0001493152-20-010889.txt   5959
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 549 MILGATE PLACE BATON ROUGE LA 70810
Business Address
KUCHARCHUK ANDREW ALBERT (Reporting) CIK: 0001654127 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52218 | Film No.: 20953369